Stock Research for APHB

APHB
Current Price

$1.2000


Latest Update: 2018-02-16 16:00:00

High
$ 1.2200
Low
$ 1.2000
Close
$ 1.2200
Volume
581
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

APHB Stock Chart & Research Data

The APHB chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the APHB chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


APHB Due diligence Resources & Stock Charts

The APHB stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View APHB Detailed Price Forecast - CNN Money CNN View APHB Detailed Summary - Google Finance
Yahoo View APHB Detailed Summary - Yahoo! Finance Zacks View APHB Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View APHB Trends & Analysis - Trade-Ideas Barrons View APHB Major Holders - Barrons
NASDAQ View APHB Call Transcripts - NASDAQ Seeking View APHB Breaking News & Analysis - Seeking Alpha
Spotlight View APHB Annual Report - CompanySpotlight.com OTC Report View APHB OTC Short Report - OTCShortReport.com
TradeKing View APHB Fundamentals - TradeKing Charts View APHB SEC Filings - Bar Chart
WSJ View Historical Prices for APHB - The WSJ Morningstar View Performance/Total Return for APHB - Morningstar
MarketWatch View the Analyst Estimates for APHB - MarketWatch CNBC View the Earnings History for APHB - CNBC
StockMarketWatch View the APHB Earnings - StockMarketWatch MacroAxis View APHB Buy or Sell Recommendations - MacroAxis
Bullish View the APHB Bullish Patterns - American Bulls Short Pains View APHB Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View APHB Stock Mentions - StockTwits PennyStocks View APHB Stock Mentions - PennyStockTweets
Twitter View APHB Stock Mentions - Twitter Invest Hub View APHB Investment Forum News - Investor Hub
Yahoo View APHB Stock Mentions - Yahoo! Message Board Seeking Alpha View APHB Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for APHB - SECform4.com Insider Cow View Insider Transactions for APHB - Insider Cow
CNBC View APHB Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for APHB - OTC Markets
Yahoo View Insider Transactions for APHB - Yahoo! Finance NASDAQ View Institutional Holdings for APHB - NASDAQ


Stock Charts

FinViz View APHB Stock Insight & Charts - FinViz.com StockCharts View APHB Investment Charts - StockCharts.com
BarChart View APHB Stock Overview & Charts - BarChart Trading View View APHB User Generated Charts - Trading View


Latest Financial News for APHB

Best High Growth AMEX Stocks This Week
Posted on Saturday January 20, 2018

Most investors find it challenging to find companies with prospective double-digit growth rates that are also financially robust. These hidden gems also add meaningful upside to a portfolio, should theRead More...


AmpliPhi Biosciences Announces Pricing of $4.0 Million Public Offering of Common Stock
Posted on Wednesday January 10, 2018

AmpliPhi Biosciences Corporation , a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced the pricing of a public offering of 4,000,000 shares of its common stock, offered at a price to the public of $1.00 per share, for gross proceeds of $4.0 million, before deducting placement agent fees and offering expenses ...


AmpliPhi Biosciences Announces Proposed Public Offering of Common Stock
Posted on Tuesday January 09, 2018

AmpliPhi Biosciences Corporation , a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that it intends to offer shares of its common stock in a public offering.


APHB: Reports Positive Interim Results for Expanded Access Program
Posted on Friday January 05, 2018

A total of seven patients with serious or life-threatening infections, which were not responding to antibiotic therapy, were treated with AB-SA01 (n=4) or AB-PA01 (n=3). AmpliPhi is developing bacteriophage therapeutics for the treatment of bacterial infections. Bacteriophages are viruses that infect, replicate in, and kill bacterial cells while not harming eukaryotic cells.


AmpliPhi Biosciences Is Making Progress But A Catalyst Is Lacking
Seeking Alpha - Oct 31, 2016
San Diego, California-based AmpliPhi was founded in 1989 as Targeted Genetics Corporation and is focused on developing various bacteriophage therapeutics.

Ampliphi Biosciences Corp.
MarketWatch - May 5, 2017
AmpliPhi Biosciences Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel phage therapeutics.

AmpliPhi Biosciences Provides Corporate and Strategic Update
Business Wire (press release) - Dec 14, 2017
“AmpliPhi has made tremendous progress throughout 2017,” said Paul C. Grint, M.D., CEO of AmpliPhi Biosciences. “To date, under the expanded access program, we have dosed seven patients in dire need, who were suffering from serious and life-threatening ...

AmpliPhi Biosciences Announces Closing of Public Offering
Business Wire (press release) - May 10, 2017
SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSE MKT: APHB), a biotechnology company focused on the development of therapies for drug-resistant bacterial infections using bacteriophage technology, today announced the closing of its ...

Enter a stock symbol to view the stock details.